Benign paroxysmal positional vertigo differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 30: | Line 30: | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
| Line 37: | Line 37: | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
! | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! colspan=" | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 1 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 1 | ||
| Line 48: | Line 47: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 3 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 3 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 1 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 1 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 1 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 1 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ||
|- | |- | ||
| colspan=" | | colspan="12" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |'''Peripheral''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |BPPV | | style="background: #DCDCDC; padding: 5px; text-align: center;" |BPPV | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 74: | Line 66: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular neuritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular neuritis | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 91: | Line 79: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |HSV oticus | | style="background: #DCDCDC; padding: 5px; text-align: center;" |HSV oticus | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 108: | Line 92: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meniere disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Meniere disease | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 125: | Line 105: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 142: | Line 118: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Perilymphatic fistula | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Perilymphatic fistula | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 160: | Line 132: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal | ||
dehiscence syndrome | dehiscence syndrome | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 177: | Line 145: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysma | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 194: | Line 158: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cogan syndrome | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cogan syndrome | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 211: | Line 171: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular schwannoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular schwannoma | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 228: | Line 184: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Otitis media | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Otitis media | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 245: | Line 197: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 262: | Line 210: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 278: | Line 222: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan=" | ! colspan="12" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Central | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migrain | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migrain | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 298: | Line 238: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 315: | Line 251: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 332: | Line 264: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain tumors | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 349: | Line 277: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 366: | Line 290: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 383: | Line 303: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Chiari malformation | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Chiari malformation | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| Line 400: | Line 316: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Parkinson | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Parkinson | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Revision as of 15:47, 6 March 2019
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating [Disease name] from other Diseases
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
OR
As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
| Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | ||||||||||
| Lab Findings | Imaging | ||||||||||
| Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Imaging 1 | Imaging 2 | |||
| Peripheral | |||||||||||
| BPPV | |||||||||||
| Vestibular neuritis | |||||||||||
| HSV oticus | |||||||||||
| Meniere disease | |||||||||||
| Labyrinthine concussion | |||||||||||
| Perilymphatic fistula | |||||||||||
| Semicircular canal
dehiscence syndrome |
|||||||||||
| Vestibular paroxysma | |||||||||||
| Cogan syndrome | |||||||||||
| Vestibular schwannoma | |||||||||||
| Otitis media | |||||||||||
| Aminoglycoside toxicity | |||||||||||
| Recurrent vestibulopathy | |||||||||||
| Central | |||||||||||
| Vestibular migrain | |||||||||||
| Epileptic vertigo | |||||||||||
| Multiple sclerosis | |||||||||||
| Brain tumors | |||||||||||
| Crebellar infarction/hemorrhage | |||||||||||
| Brain stem ischemia | |||||||||||
| Chiari malformation | |||||||||||
| Parkinson | |||||||||||